Aquestive Therapeutics, Inc. AQST Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s quick ratio?
- Aquestive Therapeutics, Inc. (AQST) reported quick ratio of 3.8× in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s quick ratio changed year-over-year?
- Aquestive Therapeutics, Inc.'s quick ratio decreased by 14.2% year-over-year, from 4.5× to 3.8×.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s quick ratio has grown at a 8.5% compound annual growth rate (CAGR), from 2× to 3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.